Need professional-grade analysis? Visit stockanalysis.com
$40.67B
34.32
194
N/A
SENORES PHARMACEUTICALS L (SENORES) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at INR893.85, up 0.40% from the previous close.
Over the past year, SENORES has traded between a low of INR652.40 and a high of INR893.85. The stock has gained 33.9% over this period. It is currently 37.0% above its 52-week low.
SENORES PHARMACEUTICALS L has a market capitalization of $40.67B, with a price-to-earnings ratio of 34.32.
Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supplements, and urinary tract generics, as well as management and consultancy services. The company was incorporated in 2017 and is based in Ahmedabad, India.
Side-by-side comparison against top Healthcare peers.